ADGI Annual EBITDA
-$219.41 M
0.00%
31 December 2021
Summary:
As of February 5, 2025, ADGI annual earnings before interest, taxes, depreciation & amortization is -$219.41 millionADGI EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADGI Quarterly EBITDA
-$51.61 M
+$49.04 M+48.72%
30 June 2022
Summary:
As of February 5, 2025, ADGI quarterly earnings before interest, taxes, depreciation & amortization is -$51.61 million, with the most recent change of +$49.04 million (+48.72%) on June 30, 2022. Over the past year, it has dropped by -$9.42 million (-22.33%).ADGI Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADGI TTM EBITDA
-$291.78 M
-$9.42 M-3.34%
30 June 2022
Summary:
As of February 5, 2025, ADGI TTM earnings before interest, taxes, depreciation & amortization is -$291.78 million, with the most recent change of -$9.42 million (-3.34%) on June 30, 2022. Over the past year, it has dropped by -$203.78 million (-231.59%).ADGI TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADGI EBITDA Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | -22.3% | -231.6% |
3 y3 years | - | -537.8% | -3505.3% |
5 y5 years | - | -537.8% | -3505.3% |
ADGI EBITDA High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | ||||||
5 y | 5-year | ||||||
alltime | all time | at high | +537.7% | +3505.3% |
Adagio Therapeutics EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2022 | - | -$51.61 M(-48.7%) | -$291.78 M(+3.3%) |
Mar 2022 | - | -$100.66 M(+21.1%) | -$282.35 M(+28.7%) |
Dec 2021 | -$219.41 M | -$83.09 M(+47.3%) | -$219.41 M(+61.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2021 | - | -$56.42 M(+33.7%) | -$136.32 M(+54.9%) |
June 2021 | - | -$42.19 M(+11.9%) | -$87.99 M(+92.1%) |
Mar 2021 | - | -$37.71 M(+365.9%) | -$45.80 M(+465.9%) |
Sept 2020 | - | -$8.09 M | -$8.09 M |
FAQ
- What is Adagio Therapeutics annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Adagio Therapeutics?
- What is Adagio Therapeutics quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Adagio Therapeutics?
- What is Adagio Therapeutics quarterly EBITDA year-on-year change?
- What is Adagio Therapeutics TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Adagio Therapeutics?
- What is Adagio Therapeutics TTM EBITDA year-on-year change?
What is Adagio Therapeutics annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of ADGI is -$219.41 M
What is the all time high annual EBITDA for Adagio Therapeutics?
Adagio Therapeutics all-time high annual earnings before interest, taxes, depreciation & amortization is -$219.41 M
What is Adagio Therapeutics quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of ADGI is -$51.61 M
What is the all time high quarterly EBITDA for Adagio Therapeutics?
Adagio Therapeutics all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$8.09 M
What is Adagio Therapeutics quarterly EBITDA year-on-year change?
Over the past year, ADGI quarterly earnings before interest, taxes, depreciation & amortization has changed by -$9.42 M (-22.33%)
What is Adagio Therapeutics TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of ADGI is -$291.78 M
What is the all time high TTM EBITDA for Adagio Therapeutics?
Adagio Therapeutics all-time high TTM earnings before interest, taxes, depreciation & amortization is -$8.09 M
What is Adagio Therapeutics TTM EBITDA year-on-year change?
Over the past year, ADGI TTM earnings before interest, taxes, depreciation & amortization has changed by -$203.78 M (-231.59%)